30-Oct-2026 07:48:20

JEFFERIES ON LAURUS LABS ; HOLD | TP ₹2,100 (EARLIER ₹1,700)

• Jefferies maintains Hold rating on Laurus Labs and raises target price to ₹2,100 from ₹1,700. • Q2 revenue grows 33% YoY, while EBITDA surges 86% YoY, with EBITDA margin expanding to 34%. • Peptide manufacturing capacity reaches 16,000 litres, with commercial revenues expected from H2 FY28/FY29. • Jefferies raises FY27 EPS estimates by 6% and FY28 estimates by 4%. • Improved product mix and strong CDMO growth support earnings upgrades.

LAURUS LABS LIMITED

← Back to feed